Abstract:Sleep apnea involves almost one billion individuals throughout the world, including 40 million Americans. Of major medical concern is the fact that the prevalence of sleep apnea is significantly increasing due to the epidemic of obesity, physical inactivity, and diabetes mellitus which are important risk factors for the development and persistence of sleep apnea in individuals. Sleep apnea is characterized by multiple episodes of apnea or hypopnea during sleep, which cause nocturnal arousals, gasping for breath during the night, daytime sleepiness, irritability, forgetfulness, fatigue and recurrent headaches. Obstructive sleep apnea occurs when upper airway obstruction occurs in an individual during sleep with absent or markedly reduced airflow in the presence of continued activity of inspiratory thoracic and diaphragmatic muscles. Central sleep apnea is defined as the absence or the significant reduction of naso-oral airflow due to the withdrawal during sleep of ponto-medullary respiratory center stimulation of the nerves of the inspiratory thoracic and diaphragmatic muscles and absence of contraction of these muscles during apnea. Complex sleep apnea occurs when an individual exhibits characteristics of both obstructive and central sleep apnea. The severity of sleep apnea is measured by polysomnography and the apnea hypopnea index (AHI), which is the average number of apneas and hypopneas per hour of sleep measured by polysomnography. Sleep apnea is mild if the AHI is 5-14/hour with no or mild symptoms, moderate if the AHI is 15 to 30/hour with occasional daytime sleepiness, and severe if the AHI is >30/hour with frequent daytime sleepiness that interferes with the normal activities of daily life. Chronic sleep apneas and hypopneas followed by compensatory hyperpneas are associated with significant adverse cardiovascular consequences including: 1) recurrent hypoxemia and hypercarbia; 2) Increased sympathetic nerve activity and decreased parasympathetic nerve activity; 3) oxidative stress and vascular endothelial dysfunction; and 4) cardiac remodeling and cardiovascular disease. Moderate or severe sleep apnea significantly increases the risk of coronary artery disease, congestive heart failure, cerebral vascular events (strokes), and cardiac dysrhythmias, and also increase the morbidity and mortality of these diseases. Nevertheless, sleep apnea is currently underdiagnosed and untreated in many individuals due to the challenges in the prediction and detection of sleep apnea and a lack of well-defined optimal treatment guidelines. Chronic continuous positive airway pressure for ≥4 hours/night for >70% of nights is beneficial in the treatment of patients with sleep apnea. CPAP Improves sleep quality, reduces the AHI, augments cardiac output and increases oxygen delivery to brain and heart, reduces resistant hypertension, decreases cardiac dysrhythmias, and reduces daytime sleepiness. The present article discusses the diagnosis of obstructive sleep apnea, central sleep apnea, and complex apnea. Thereafter the important pathophysiologic mechanisms in sleep apnea and the relationship of these pathophysiologic mechanics to atherosclerotic vascular disease are reviewed. Guidelines are then provided for the treatment of mild, moderate and severe sleep apnea In order to reduce the cardiovascular morbidity and mortality caused by sleep apnea and facilitate the diagnosis and the long-term, effective treatment of sleep apnea in patients, the close cooperation is necessary of cardiovascular specialists, pulmonary specialists, and respiratory therapy/ rehabilitation specialists.

Sleep apnea: Clinical investigations in humans

Obstructive sleep apnea: Part I. Pathophysiology, diagnosis, and medical management.

[Sleep-related breathing disorders in adults: diagnosis, consequences and comorbidities]

Obstructive Sleep Apnea in Adults: Common Questions and Answers

Obstructive Sleep Apnea in Adults: Epidemiology, Clinical Presentation, and Treatment Options

Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome

Sleep disorders and upper airway obstruction in adults

SLEEP APNEA IS A COMMON AND DANGEROUS CARDIOVASCULAR RISK FACTOR

Clinical characteristics and adaptive servo-ventilation treatment outcomes of complex sleep apnea syndrome.

Consequences and factors associated with OSA: a brief review

Sleep Disorders: Sleep-Related Breathing Disorders

CARDIOVASCULAR DISEASES AND OBSTRUCTIVE SLEEP APNEA SYNDROME. REVIEW

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

[Screening of sleep apnea syndrome-a review of current situation].

Possible Molecular Mechanisms of Hypertension Induced by Sleep Apnea Syndrome/Intermittent Hypoxia

Research progress on the relationship between obstructive sleep apnea syndrome and diseases of the respiratory and circulatory systems

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

Central sleep apnea: emphasizing recognition and differentiation

Insights, recommendations, and research priorities for central sleep apnea: report from an expert panel

The relationships between intermittent hypoxia and oxidative stress in patients with sleep apnea syndrome

The Treatment Research Progress of Elderly Sleep Apnea Syndrome in China